Stock-Based Compensation (Tables)
|
6 Months Ended |
Jul. 31, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Share-Based Compensation Expense |
The following table summarizes the Company's stock-based compensation expense for equity classified awards for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | (in thousands) | 2026 | | 2025 | | 2026 | | 2025 | | Equity classified awards: | | | | | | | | | Cost of revenue | $ | 488 | | | $ | 729 | | | $ | 966 | | | $ | 1,400 | | | Sales and marketing | 1,841 | | | 704 | | | 3,482 | | | 3,115 | | | Research and development | 2,952 | | | 3,818 | | | 6,312 | | | 6,952 | | | General and administrative | 4,680 | | | 7,711 | | | 9,235 | | | 14,154 | | | Total stock-based compensation expense | $ | 9,961 | | | $ | 12,962 | | | $ | 19,995 | | | $ | 25,621 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | (in thousands) | 2026 | | 2025 | | 2026 | | 2025 | | Liability classified awards: | | | | | | | | | Cost of revenue | $ | 3 | | | $ | 225 | | | $ | 9 | | | $ | 716 | | | Sales and marketing | 30 | | | 100 | | | 91 | | | 573 | | | Research and development | 21 | | | 514 | | | 65 | | | 1,201 | | | General and administrative | 4 | | | 54 | | | 12 | | | 235 | | Total compensation expense | $ | 58 | | | $ | 893 | | | $ | 177 | | | $ | 2,725 | |
|
| Schedule of Stock Options Activity |
The following table summarizes the activity related to the Company's stock options: | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | Outstanding Stock Options | | Weighted-Average Exercise Price | | Weighted-Average Remaining Contractual Life (in years) | | Aggregate Intrinsic Value
(in thousands) | Balance, January 31, 2026 | 1,178,814 | | | $ | 6.75 | | | 0.56 | | $ | 665 | | | Granted | — | | | $ | — | | | | | | | Exercised | — | | | $ | — | | | | | | Forfeited/canceled/expired | (678,575) | | | $ | 6.39 | | | | | | Balance, July 31, 2026 | 500,239 | | | $ | 7.24 | | | 0.31 | | $ | — | | | Vested and expected to vest | 500,239 | | | $ | 7.24 | | | 0.31 | | $ | — | | Exercisable, July 31, 2026 | 500,239 | | | $ | 7.24 | | | 0.31 | | $ | — | |
|
| Schedule of Restricted Stock and Restricted Stock Units |
The following table summarizes the activity related to the Company's restricted stock and restricted stock units ("RSUs"): | | | | | | | | | | | | | Outstanding | | Weighted-Average Grant Date Fair Value | Balance, January 31, 2026 | 7,607,861 | | | $ | 7.51 | | | Granted | 3,660,655 | | | $ | 3.71 | | | Vested and converted to shares | (2,907,326) | | | $ | 7.08 | | | Forfeited or canceled | (401,043) | | | $ | 7.72 | | Balance, July 31, 2026 | 7,960,147 | | | $ | 5.90 | |
|
| Schedule of Performance-Based Restricted Stock Units |
The following table summarizes the activity related to the Company’s PSUs: | | | | | | | | | | | | | Number of PSUs | | Weighted-Average Grant Date Fair Value | Balance, January 31, 2026 | 3,825,000 | | | $ | 6.31 | | | Granted | 7,333,478 | | | $ | 2.88 | | Achievement of awards in excess of target(1) | 89,498 | | | $ | 7.17 | | | Vested | (1,168,435) | | | $ | 6.82 | | | Forfeited or canceled | (58,563) | | | $ | 6.44 | | Balance, July 31, 2026 | 10,020,978 | | | $ | 3.75 | |
(1) Relates to awards granted during fiscal 2026 based on ARR and Adjusted EBITDA margin growth metrics.
|